Assistant Professor, Medicine, Vanderbilt University School of Medicine
Internal Medicine
Dr. Anna R. Hemnes, MD
|
|
Give Review
Anna Hemnes is an expert in the field of Internal Medicine. He graduated from Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is one of the top medical schools in the US. Johns Hopkins University School of Medicine is ranked 3 in research and 29 in primary care medicine Dr. Anna R. Hemnes is a published doctor. He published 54 publications, including: 'The Epstein-Barr virus nuclear antigen leader protein associates with hsp72/hsc73.'
Publications
- Endothelial HIF signaling regulates Pulmonary fibrosis-associated Pulmonary hypertension.
- Valsalva Maneuver in Pulmonary Arterial Hypertension: Susceptibility to Syncope and Autonomic Dysfunction.
- Metabolic dysfunction in Pulmonary arterial hypertension.
- Prognostic value of acute vasodilator response in Pulmonary arterial hypertension: Beyond the "classic" responders.
- Variability in hemodynamic evaluation of Pulmonary hypertension at large referral centers.
- Serum Endostatin is a Genetically Determined Predictor of Survival in Pulmonary Arterial Hypertension.
- Impact of diabetes on survival and right ventricular compensation in Pulmonary arterial hypertension.
- One generation's "junk" is another's treasure: The emerging role of microRNAs as therapeutic targets.
- An evidence-based knowledgebase of Pulmonary arterial hypertension to identify genes and pathways relevant to pathogenesis.
- Evidence for Right Ventricular Lipotoxicity in Heritable Pulmonary Arterial Hypertension.
- Interaction between bone morphogenetic protein receptor type 2 and estrogenic compounds in Pulmonary arterial hypertension.
- Shorter survival in familial versus idiopathic Pulmonary arterial hypertension is associated with hemodynamic markers of impaired right ventricular function.
- Reproducibility of intracardiac and transPulmonary biomarkers in the evaluation of Pulmonary hypertension.
- Genome-wide association analysis identifies a susceptibility locus for Pulmonary arterial hypertension.
- Physical activity limitation as measured by accelerometry in Pulmonary arterial hypertension.
- A potential role for Insulin resistance in experimental Pulmonary hypertension.
- Longitudinal Analysis Casts Doubt on the Presence of Genetic Anticipation in Heritable Pulmonary Arterial Hypertension.
- Testosterone negatively regulates right ventricular load stress responses in mice.
- Right ventricular plasticity and functional imaging.
- Metabolomic analysis of bone morphogenetic protein receptor type 2 mutations in human Pulmonary endothelium reveals widespread metabolic reprogramming.
- Cytoskeletal defects in Bmpr2-associated Pulmonary arterial hypertension.
- Programmatic change: lung Disease research in the era of induced pluripotency.
- End tidal CO(2) tension: Pulmonary arterial hypertension vs Pulmonary venous hypertension and response to treatment.
- Left atrial Hypertension after repeated catheter ablations for atrial fibrillation.
- Unrecognized glucose intolerance is common in Pulmonary arterial hypertension.
- Oxidative injury is a common consequence of BMPR2 mutations.
- ACE2 Improves Right Ventricular Function in a Pressure Overload Model.
- The right ventricle in Pulmonary hypertension: from dogma to data.
- Congenital pulmonary artery stenoses masquerading as Chronic thromboembolic disease.
- Association of the metabolic syndrome with Pulmonary venous hypertension.
- Impact of medical residency on knowledge of Asthma.
- Sildenafil monotherapy in portoPulmonary hypertension can facilitate liver transplantation.
- PDE5A inhibitor treatment of persistent Pulmonary hypertension after mechanical circulatory support.
- Hysteroscopic sterilization in women with Pulmonary vascular disease.
- Hyponatremia predicts right heart failure and poor survival in Pulmonary arterial hypertension.
- Poor outcomes associated with drainage of pericardial effusions in patients with Pulmonary arterial hypertension.
- PDE5A inhibition attenuates bleomycin-induced Pulmonary fibrosis and Pulmonary hypertension through inhibition of ROS generation and RhoA/Rho kinase activation.
- Growth by association.
- Tricuspid annular displacement predicts survival in Pulmonary hypertension.
- A pressing situation.
- Diagnosing acute pancreatitis.
- Predictors of diastolic-to-wedge gradient in patients evaluated for Pulmonary hypertension.
- Sildenafil, a PDE5 inhibitor, in the treatment of Pulmonary hypertension.
- Right heart function and haemodynamics in Pulmonary hypertension.
- Bedside end-tidal CO2 tension as a screening tool to exclude Pulmonary embolism.
- Assessment of Pulmonary vasculature and right heart by invasive haemodynamics and echocardiography.
- The Epstein-Barr virus nuclear antigen leader protein associates with hsp72/hsc73.
- Development of Pulmonary arterial hypertension in women: interplay of sex hormones and Pulmonary vascular disease.
- Idiopathic and heritable PAH perturb common molecular pathways, correlated with increased MSX1 expression.
- Phosphodiesterase-5A (PDE5A) is localized to the endothelial caveolae and modulates NOS3 activity.
- Pulmonary hypertension in women.
- Safety of sapropterin dihydrochloride (6r-bh4) in patients with Pulmonary hypertension.
- Metabolic and hormonal derangements in Pulmonary hypertension: from mouse to man.
Schools
Johns Hopkins University School of Medicine
Procedures Preformed
- Bronchoscopy
Conditions Treated
- Asthma
- Bronchitis
- Chronic Pulmonary Heart Diseases (incl. Pulmonary Hypertension)
- COPD (Chronic Obstructive Pulmonary Disease)
- View All
Doctors Specialties
- Critical Care Medicine
- Pulmonology
- Internal Medicine
Accepted Insurances
- Amerigroup (Wellpoint)
- Blue Card PPO
- Network S
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Choice Care PPO
- Medicare MCR
- PHCS Network PPO
- Mutual of Omaha
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
Johns Hopkins University -
Johns Hopkins University School of Medicine
Hospital
-
Vanderbilt Hospital and Clinics
Drug Facts
| NPI NUMBER | 1669529616 | |
| NPPES Provider LastName | HEMNES | |
| NPPES Provider FirstName | ANNA | |
| NPPES Provider ZIPCode | 37232 | |
| NPPES Provider State | TN | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 924.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1669529616 |
| Last Name Of The Provider | HEMNES |
| First Name Of The Provider | ANNA |
| View All |
Similar Doctors
|
Dr. John T. Shaw, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. John G. Thompson Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kenneth E. Vargas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jan Delozier, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karl B. Hammonds, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kaylin C. Smith, MD |
|
|
Dr. Bijoy E. John, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James Loyd, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Asad A. Al Aboud, MD |
|
|
Dr. Michael A. Duncan, MD |
|
|
Dr. John M. Bolds, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher G. Hughes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lawrence W. Freund, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason D. Kennedy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tracy J. McGrane, MD
This Doctor is OpenDoctor Recommended.
|